| Entry |
|
| Name |
Nizatidine (JP18/USP/INN); Acinon (TN); Axid (TN) |
| Product |
|
| Generic |
NIZATIDINE (Actavis Pharma), NIZATIDINE (Amneal Pharmaceuticals LLC), NIZATIDINE (Amneal Pharmaceuticals LLC), NIZATIDINE (Bryant Ranch Prepack), NIZATIDINE (Bryant Ranch Prepack), NIZATIDINE (Dr Reddy's Laboratories Limited), NIZATIDINE (Glenmark Pharmaceuticals), NIZATIDINE (NuCare Pharmaceuticals), NIZATIDINE (NuCare Pharmaceuticals), NIZATIDINE (Proficient Rx LP) |
| Formula |
C12H21N5O2S2
|
| Exact mass |
331.1137
|
| Mol weight |
331.4574
|
| Structure |

|
| Simcomp |
|
| Class |
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG01481 Histamine receptor H2 antagonist
|
| Remark |
| Therapeutic category: | 2325 |
|
| Efficacy |
Anti-ulcerative, H2 receptor antagonist |
| Disease |
Duodenal ulcer [DS:H01634] GERD [DS:H01602] Gastric ulcer [DS:H01634] |
| Target |
HRH2 [HSA:3274] [KO:K04150] |
| Pathway |
| hsa04020 | Calcium signaling pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04971 | Gastric acid secretion |
|
| Interaction |
|
| Structure map |
| map07227 | Histamine H2/H3 receptor agonists/antagonists |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02BA H2-receptor antagonists
A02BA04 Nizatidine
D00440 Nizatidine (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Histamine2 (H2) Receptor Antagonists
Nizatidine
D00440 Nizatidine (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
23 Digestive organ agents
232 Peptic ulcer agents
2325 H2 blockers
D00440 Nizatidine (JP18/USP/INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for digestive organs
09 Histamine H2 receptor blocker containing drugs
D00440 Nizatidine (JP18/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Nizatidine
D00440 Nizatidine (JP18/USP/INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG01481 Histamine receptor H2 antagonist
D00440 Nizatidine
Drug classes [BR:br08332]
Gastrointestinal agent
DG01481 Histamine receptor H2 antagonist
D00440 Nizatidine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH2
D00440 Nizatidine (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00440 Nizatidine
D00440 Nizatidine capsules
Rx-to-OTC switch list in the USA [br08315.html]
D00440
Rx-to-OTC switch list in Japan [br08314.html]
D00440
|
| Other DBs |
|
| KCF data |
ATOM 21
1 C1b C 21.6127 -25.2508
2 S2a S 22.8717 -24.5514
3 C1b C 24.0608 -25.2508
4 C1b C 25.2498 -24.5514
5 N1b N 26.5088 -25.2508
6 C2c C 27.6979 -24.5514
7 C8y C 20.4236 -24.5514
8 N5x N 20.4236 -23.1525
9 C8y C 19.0946 -22.7328
10 S2x S 18.2553 -23.8519
11 C8x C 19.0946 -24.9710
12 C1b C 18.6750 -21.4038
13 C2b C 28.9569 -25.2508
14 N1c N 17.3091 -21.1017
15 C1a C 16.3385 -22.1622
16 C1a C 16.8910 -19.7792
17 N2b N 30.1567 -24.5315 #+
18 O3a O 31.3796 -25.2108
19 O3a O 30.1338 -23.1526 #-
20 N1b N 27.7512 -23.1705
21 C1a C 26.5443 -22.4100
BOND 21
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 7 1
7 7 8 1
8 8 9 2
9 9 10 1
10 10 11 1
11 7 11 2
12 9 12 1
13 6 13 2
14 12 14 1
15 14 15 1
16 14 16 1
17 13 17 1
18 17 18 2
19 17 19 1
20 6 20 1
21 20 21 1
|